Roth Capital Partners Facilitates CapsoVision’s $27.5 Million IPO
Roth Capital Partners, a leading investment bank, has successfully acted as joint book-running manager for CapsoVision, Inc.’s initial public offering (IPO), raising approximately $27.5 million. CapsoVision, a commercial-stage medical technology company specializing in AI-powered capsule endoscopy solutions, offered 5,500,000 shares of common stock at $5.00 per share. The shares commenced trading on the Nasdaq Capital […]